HOME » News & Media

    Vyome Biosciences Appoints Angelo Secci, MD, as Chief Medical Officer

    28 Aug 2017

    Vyome Biosciences Appoints Angelo Secci, MD, as Chief Medical Officer....

    View More
    Vyome published research paper on VB 001 Leave-On lotion in BMC Journal.

    03 Jul 2017

    Vyome published research paper in reputed journal BMC...

    View More
    Vyome Biosciences to Present Corporate and Pipeline Overview at BIO International Convention

    16 Jun 2017

    CEO Venkateswarlu Nelabhotla to discuss novel and unique pipeline targeting antimicrobial resistant ...

    View More
    Vyome Completes Enrollment for POC Clinical Study of VB 1953

    24 Apr 2017

    Vyome announced completion of patient enrollment for Proof of Concept Study for VB 1953 for treatmen...

    View More
    Vyome Announces Top-line Results from Phase 1 Study of VB-1953 for Patients with Facial Acne Vulgaris

    07 Feb 2017

    Vyome announced top-line data from its phase 1 clinical trial evaluating VB-1953, a topically admini...

    View More
    N. Venkat Talks About Vyome's Drug Development Strategy for Treatment of Antibiotic Resistance

    22 Jan 2017

    Co-Founder & CEO of Vyome Biosciences N. Venkat talks to Economic Times about how Vyome is developin...

    View More

    Copyright © 2015 Vyome Biosciences. All rights reserved.